Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
September 30, 2026 574.40M
June 30, 2026 106.57M
Date Value
March 31, 2026 131.89M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Korsana Biosciences, Inc. 416.53M
IRulya Therapeutics, Inc. 78.11M
PepGen Inc. 103.07M
Q32 Bio, Inc. 287.67M
Bridgebio Oncology Therapeutics, Inc. 293.39M

Shareholders Equity (Quarterly) Related Metrics